Cellarity, a biotechnology company developing cell state-correcting therapies through integrated multi-omics and AI modeling, ...
Researchers have revealed a novel mechanism by which the chromatin remodeler brahma-related gene 1 (Brg1) regulates Group 2 ...
One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...
DNA sequencing alone misses many disease dynamics. Researchers are turning to epigenomic profiling, especially the biomarker ...
What happens when you squeeze DNA? Can pressure reveal something about how our genetic material is packed, protected, and accessed?Dr. Kushol Gupta, a ...
Three copies of chromosome 21 causes Down syndrome (DS), and roughly half of children born each year in the United States with DS—approximately ...
The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.
Mid-zone hepatocytes trade proliferation for survival via Atf4-Chop axis in early acute liver injury
This study addresses an important question in liver biology: how zonal hepatocytes balance survival and proliferation following injury; using spatial transcriptomics, mechanistic perturbations, and ...
MIT scientists have overturned the belief that genome structure vanishes during cell division. Using high-resolution genome ...
Background Many observational studies highlight clonal haematopoiesis (CH) as a novel determinant of cardiovascular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback